Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ia B, Kalyn"'
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 114(6 Pt 2)
Objective. A comparative evaluation of the efficacy and safety of a multimodal antidepressant therapy with venlafaxine plus cerebrolysin and monotherapy with the same antidepressant for the treatment of depression in elderly patients in a psychiatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67fdd49c489d9f020c7953c15b5c4ad0
https://pubmed.ncbi.nlm.nih.gov/25042499
https://pubmed.ncbi.nlm.nih.gov/25042499
[Efficacy of actovegin in the treatment of elderly patients with vascular mild cognitive impairment]
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 113(7 Pt 2)
Efficacy of actovegin was investigated in the treatment of mild cognitive impairment (MCI) of cerebrovascular genesis. Thirty patients (7 men and 23 women, mean age 71.2 years) received actovegin intramuscularly in dosage 5 ml (200 mg) daily during 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4dc2138c1006f19da42cf9f7d4063033
https://pubmed.ncbi.nlm.nih.gov/23994934
https://pubmed.ncbi.nlm.nih.gov/23994934
Autor:
S I, Gavrilova, I V, Kolykhalov, Ia B, Fedorova, Ia B, Kalyn, N D, Selezneva, A V, Samorodov, S N, Miasoedov, I S, Boksha
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 113(3)
The aim of the study was to predict treatment efficacy in patients with mild cognitive impairment (MCI) and to find the most reliable clinical tests for the prediction of dementia. Patients with amnestic MCI (n=53) were treated with cerebrolysin for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2664c4018935c35342434c811c69e11f
https://pubmed.ncbi.nlm.nih.gov/23612410
https://pubmed.ncbi.nlm.nih.gov/23612410
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 111(12)
The objective was to study efficacy and safety of ceraxon (citicoline) used perorally in dose 1000 mg daily in the treatment of cognitive disturbances in patients with amnesic type of mild cognitive impairment (MCI). Twenty patients, aged from 50 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::858578fffed68cebff498e3d7ad24c49
https://pubmed.ncbi.nlm.nih.gov/22433803
https://pubmed.ncbi.nlm.nih.gov/22433803
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 111(9)
Efficacy, safety and tolerability of acetyl-L-carnitine (ALC) were studied during the double-blind placebo-controlled 12-week trial in patients with mild (initial) dementia caused by the Alzheimer's disease (AD) and vascular dementia (VD). ALC was ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5e447d2249eb0becb7ebabe51fae1df7
https://pubmed.ncbi.nlm.nih.gov/22027664
https://pubmed.ncbi.nlm.nih.gov/22027664
Autor:
S I, Gavrilova, I V, Kolykhalov, Ia B, Fedorova, N D, Selezneva, Ia B, Kalyn, I F, Roshchina, M M, Odinak, A Iu, Emelin, A V, Kashin, A V, Gustov, E A, Antipenko, Iu A, Korshunova, T A, Davydova, G, Messler
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 110(1)
The study was conducted in 3 Russian centers (Moscow, St. Petersburg and Nizhniy Novgorod). The total sample included 110 patients whose mental state met the definition ofmild cognitive impairment(MCI). Patient's status was assessed with widely used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e51ec0da722376dfc921b28407081be
https://pubmed.ncbi.nlm.nih.gov/20436440
https://pubmed.ncbi.nlm.nih.gov/20436440
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 109(7)
Twenty-five patients with Alzheimer's disease (AD) in moderate-severe and severe stages received galantamine in dosage 8 mg daily during the 1st month with the following increasing to 16 mg daily. Six patients received 24 mg per day from the 3rd mont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b082d7f4e7d84797a32128dde6e49ee
https://pubmed.ncbi.nlm.nih.gov/19672237
https://pubmed.ncbi.nlm.nih.gov/19672237
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 108(7)
To study efficacy and safety of cholinergic therapy in patients with Alzheimer's disease or combined Alzheimer's and vascular dementia and marked somatic pathology, 30 patients, aged from 54-85 years, with mild or moderate dementia have been studied.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4af90a1de97ffd5a35922c8849988f39
https://pubmed.ncbi.nlm.nih.gov/18833116
https://pubmed.ncbi.nlm.nih.gov/18833116
Autor:
S I, Gavrilova, Ia B, Fedorova, I V, Kolykhalov, M M, Odinak, A Iu, Emelin, A V, Kashin, N D, Selezneva, Ia B, Kalyn, I F, Roshchina
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 108(8)
A potential of prolonged 2-years course of cerebrolysin therapy with courses repeated every 6 months to slow down or prevent the transition of the syndrome of mild cognitive impairment, amnestic type, to clinically relevant dementia has been studied
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::59a6f86845f1e52de2c225a5735c5a3d
https://pubmed.ncbi.nlm.nih.gov/18833104
https://pubmed.ncbi.nlm.nih.gov/18833104
Autor:
S I, Gavrilova, I V, Kolykhalov, G I, Korovaĭtseva, G A, Zharikov, Ia B, Kalyn, N D, Selezneva
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 105(4)
Correlation association between an ApoE4 genotype in patients with mild-moderate Alzheimer's disease and efficacy of neurotrophic (cerebrolysin) and cholinergic (exelon) therapy was studied in the groups of patients formed using case-control method.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::059bf5cabf413090b7de418576b9f4c4
https://pubmed.ncbi.nlm.nih.gov/15880838
https://pubmed.ncbi.nlm.nih.gov/15880838